Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1xdk | REA | Retinoic acid receptor beta |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1xdk | REA | Retinoic acid receptor beta | / | 1.000 | |
| 4dm8 | REA | Retinoic acid receptor beta | / | 0.606 | |
| 4dm6 | TTB | Retinoic acid receptor beta | / | 0.576 | |
| 1exa | 394 | Retinoic acid receptor gamma | / | 0.574 | |
| 1fd0 | 254 | Retinoic acid receptor gamma | / | 0.570 | |
| 1fcx | 184 | Retinoic acid receptor gamma | / | 0.560 | |
| 1fcy | 564 | Retinoic acid receptor gamma | / | 0.556 | |
| 2lbd | REA | Retinoic acid receptor gamma | / | 0.539 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.504 | |
| 1h36 | R88 | Squalene--hopene cyclase | 4.2.1.129 | 0.489 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.471 | |
| 3irx | UDR | Gag-Pol polyprotein | 2.7.7.49 | 0.466 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.460 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.460 | |
| 1iyz | NDP | Probable quinone oxidoreductase | / | 0.459 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.459 | |
| 3tda | PN0 | Cytochrome P450 2D6 | / | 0.457 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.457 | |
| 1yc2 | NAD | NAD-dependent protein deacylase 2 | / | 0.456 | |
| 2qjy | SMA | Cytochrome b | / | 0.456 | |
| 4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.456 | |
| 3cxh | SMA | Cytochrome b | / | 0.455 | |
| 3tm5 | SFG | Uncharacterized protein | / | 0.455 | |
| 2e99 | B08 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.453 | |
| 1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.452 | |
| 2ykj | YKJ | Heat shock protein HSP 90-alpha | / | 0.452 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.452 | |
| 3tfy | COA | N-alpha-acetyltransferase 50 | 2.3.1 | 0.451 | |
| 1o6r | R19 | Squalene--hopene cyclase | 4.2.1.129 | 0.449 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.449 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.449 | |
| 3jyn | NDP | Quinone oxidoreductase | / | 0.449 | |
| 3nal | DBK | Calcium-transporting ATPase | / | 0.449 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.449 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.449 | |
| 2acl | L05 | Oxysterols receptor LXR-alpha | / | 0.448 | |
| 2yki | YKI | Heat shock protein HSP 90-alpha | / | 0.448 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.448 | |
| 2fs4 | PZ1 | Renin | 3.4.23.15 | 0.447 | |
| 4j6d | TES | Cytochrome P450 monooxygenase | / | 0.447 | |
| 3ol5 | SAW | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 3aba | FLI | Cytochrome P450 | / | 0.445 | |
| 1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.444 | |
| 1ia4 | TQ6 | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
| 2yjx | YJX | Heat shock protein HSP 90-alpha | / | 0.444 | |
| 3jpu | TY4 | Transcriptional activator protein LasR | / | 0.444 | |
| 3p6o | ETG | Camphor 5-monooxygenase | 1.14.15.1 | 0.443 | |
| 3u8h | BHP | Phospholipase A2, membrane associated | / | 0.443 | |
| 4mfb | 29T | Gag-Pol polyprotein | 2.7.7.49 | 0.443 | |
| 3up3 | XCA | aceDAF-12 | / | 0.442 | |
| 1ezf | IN0 | Squalene synthase | 2.5.1.21 | 0.441 | |
| 2a4n | COA | Aac(6')-Ii protein | / | 0.441 | |
| 1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.440 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.440 |